These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31200801)

  • 21. What can be achieved by redesigning stroke care for a value-based world?
    Tai W; Kalanithi L; Milstein A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):585-7. PubMed ID: 25095813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis: role and implications.
    Marsden G; Wonderling D
    Phlebology; 2013 Mar; 28 Suppl 1():135-40. PubMed ID: 23482549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative's Prior Authorization Learning Collaborative.
    Psotka MA; Singletary EA; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; McClellan MB; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006564. PubMed ID: 32683983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Value of Preoperative Assessment Before Noncardiac Surgery in the Era of Value-Based Care.
    Fleisher LA
    Circulation; 2017 Nov; 136(19):1769-1771. PubMed ID: 29109193
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of supervised exercise therapy in heart failure patients.
    Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early decision-analytic modeling - a case study on vascular closure devices.
    Brandes A; Sinner MF; Kääb S; Rogowski WH
    BMC Health Serv Res; 2015 Oct; 15():486. PubMed ID: 26507131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
    Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value-based Healthcare: A Novel Transitional Care Service Strives to Improve Patient Experience and Outcomes.
    Vetter TR; Uhler LM; Bozic KJ
    Clin Orthop Relat Res; 2017 Nov; 475(11):2638-2642. PubMed ID: 28840467
    [No Abstract]   [Full Text] [Related]  

  • 29. Value in Healthcare Initiative: Summary and Key Recommendations.
    Joynt Maddox KE; Bleser WK; Das SR; Desai NR; Ng-Osorio J; O'Brien E; Psotka MA; Wadhera RK; Weintraub WS; Konig M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006612. PubMed ID: 32683984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Numbers needed to treat (lives!) and numbers needed to save (money).
    Ribichini F; Taggart D; Vassanelli C
    EuroIntervention; 2013 Jun; 9(2):175-7. PubMed ID: 23793004
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcome Measurement in Value-Based Payments.
    Mullangi S; Schleicher S; Feeley TW
    JAMA Oncol; 2017 Aug; 3(8):1019-1020. PubMed ID: 27918757
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
    Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
    Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting.
    Swart ECS; Parekh N; Daw J; Manolis C; Good CB; Neilson LM
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1385-1389. PubMed ID: 33119437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
    Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value-based Healthcare: Can Artificial Intelligence Provide Value in Orthopaedic Surgery?
    Jayakumar P; Moore MLG; Bozic KJ
    Clin Orthop Relat Res; 2019 Aug; 477(8):1777-1780. PubMed ID: 31335596
    [No Abstract]   [Full Text] [Related]  

  • 37. [Analysis of cost-effectiveness of simvastatin versus atorvastatin in the secondary prevention of cardiovascular events within the Brazilian public healthcare system].
    Araujo DV; Ribeiro de Souza CP; Bahia LR; Rey HC; Dos Santos Junior B; Tura BR; Berwanger O; Buehler AM; Silva MT
    Value Health; 2011; 14(5 Suppl 1):S29-32. PubMed ID: 21839894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Faceoff: How Does Patient Satisfaction Fit Into the Value Equation?
    Delanois RE; Mont MA; Huddleston JI
    Clin Orthop Relat Res; 2018 Jan; 476(1):21-24. PubMed ID: 29389756
    [No Abstract]   [Full Text] [Related]  

  • 39. A Cost-Effectiveness Analysis of Minimally Invasive versus Open Surgery Techniques for Lumbar Spinal Fusion in Italy and the United Kingdom.
    Vertuani S; Nilsson J; Borgman B; Buseghin G; Leonard C; Assietti R; Quraishi NA
    Value Health; 2015 Sep; 18(6):810-6. PubMed ID: 26409608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A primer on cost-effectiveness analyses for vascular surgeons.
    Barshes NR; Chambers JD; Cantor SB; Cohen J; Belkin M
    J Vasc Surg; 2012 Jun; 55(6):1794-800. PubMed ID: 22608043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.